Abstract: Disclosed are methods of identifying a secretome from a subject cell within a heterogeneous cell population when the subject cell contacts a target cell (e.g. a subject immune cell contacts a target cancer cell) or a stimulatory agent and methods of using the identified secretome to identify cells that are safe and efficacious for cellular therapies, including adoptive CAR T-cell therapies.
Abstract: A method for synthesizing single-stranded DNA, specifically a process for producing single-stranded DNA without base mutations, is provided, by which single-stranded DNA is produced by uracil-specific excision reagent (USER)-mediated self-looping of double-stranded DNA combined with rolling circle replication.
Type:
Grant
Filed:
December 27, 2019
Date of Patent:
March 18, 2025
Assignee:
Jiangsu Genscript Biotech Co., Ltd.
Inventors:
Lumeng Ye, Haiye Sun, Yifan Li, Cheng-Hsien Wu
Abstract: Bioreactor systems and controlled operation of bioreactor systems are disclosed herein. The bioreactor systems can include at least one bioreactor chamber, at least one reservoir, a plurality of sensors, and a fluid circuit. The operational methods disclosed herein are directed towards growing cells or tissue while measuring various parameters, and a controlled operation of the various parameters during the operation of the bioreactor systems. The controlled operation of the parameters includes, for example, cell concentration; a rate of flow; a volume; a pH; a temperature; a level of oxygen; a level of carbon dioxide; a level of bicarbonate ion; nutrient compound; and any combination thereof.
Abstract: A granule for detecting occult blood in pet urine including 50-70 parts by weight of an adsorbent, 50-60 parts by weight of a filler, 3-5 parts by weight of an antibacterial agent, 5-10 parts by weight of a deodorant, 2-4 parts by weight of cumene hydroperoxide, and 2-4 parts by weight of an indicator.
Abstract: The present invention relates to a composition comprising Pediococcus pentosaceus, one or more yeast, wherein a weight ratio of Pediococcus pentosaceus:yeast is between 0.01 to 0.5:1, and optionally one or more minerals, sugar and pharmaceutical acceptable excipients, additives and/or adjuvants. The invention also relates to a use of the composition as food supplement or in treatment and/or prevention of a disease in a mammal, such as a human and a use in treatment and/or prevention of food and/or alcohol poisoning in a mammal.
Abstract: The present invention relates to compositions and methods for activating expression from the paternally-inherited allele of UBE3A in human Angelman's Syndrome neurons using viral vector delivery of short hairpin RNAs, ribozymes, and/or microRNAs.
Abstract: The present invention relates to the field of biomedicine, and in particular to an engineered migrasome, a method for preparing the engineered migrasome, a delivery system comprising the engineered migrasome, and a method for preparing the delivery system.
Type:
Grant
Filed:
July 13, 2023
Date of Patent:
February 11, 2025
Assignee:
BEIJING MIGRASOME THERAPEUTICS LIMITED
Inventors:
Li Yu, Dongju Wang, Chen Dai, Moye Jia, Shuo Wang, Tianlun Ding, Qiushi Zhong, Yi Zheng
Abstract: Described herein are probiotics, more particularly [to] the probiotic yeast Saccharomyces boulardii. Even more particularly described herein are enhanced probiotic potency S. boulardii. Also described here are mutant alleles useful to develop yeast strains with enhanced production of acetic acid. In addition, described here is the use of such yeast strains for the production of dietary supplements or pharmaceutical compositions to improve gastrointestinal comfort.
Abstract: Compositions and methods for mucosal delivery of agents are provided. The emulsion compositions are intended for administration to a mucosal surface, such as oral, gastrointestinal and nasal mucosa. The emulsion compositions provided contain one or more mucoadhesive proteins and an agent to be delivered. Methods for delivery of agents using the compositions provided herein are also provided.
Abstract: The present application relates to a psicose-6-phosphate phosphatase comprising motif A and motif B, a composition for producing D-psicose comprising the enzyme, and a method for producing D-psicose using the enzyme.
Type:
Grant
Filed:
July 25, 2018
Date of Patent:
January 21, 2025
Assignee:
CJ CHEILJEDANG CORPORATION
Inventors:
Byung-Sam Son, Hyun Kug Cho, Sung Jae Yang, Seong Bo Kim, Seung Hwan Kim, Hyun June Park
Abstract: The present invention comprises methods and compositions comprising a microalgae consortium. A composition comprises at least one genera of microalgae flocculated by Paenibacillus polymyxa strain, Strain 2, deposited under the Budapest Treaty as ATCC Accession No. PTA-12841. Methods of treating the soil comprise adding a composition of the present invention to soil.
Abstract: The present disclosure provides dimeric antigen receptors (DAR) constructs comprising a heavy chain binding region on one polypeptide chain and a light chain binding region on a separate polypeptide chain. The two polypeptide chains that make up the dimeric antigen receptors can dimerize to form an antigen binding domain. The dimeric antigen receptors have antibody-like properties as they bind specifically to a target antigen. The dimeric antigen receptors can be used for directed cell therapy.
Type:
Grant
Filed:
September 4, 2020
Date of Patent:
December 31, 2024
Assignee:
Vivasor, Inc.
Inventors:
Henry Hongjun Ji, Wenzhong Guo, Yanliang Zhang, Gunnar F. Kaufmann, Bei Bei Ding
Abstract: Provided is a method of producing monophosphoryl lipid A (MPLA). According to the method, MPLA may be produced with high purity and high purity by using a bacterium producing MPLA.
Type:
Grant
Filed:
August 26, 2020
Date of Patent:
December 24, 2024
Assignees:
EUBIOLOGICS CO., LTD., KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
Inventors:
Chan Kyu Lee, Da Hui Ha, Choon Geun Lee, Ye Ram Lee, Hak Suk Chung
Abstract: The invention discloses a genetically engineered bacterium in which the gene encoding adenine deaminase on the genome of the bacterium is knocked out or/and the gene encoding the enzyme in the NAD+ anabolic pathway is integrated on the genome of the bacterium. The invention also discloses a construction method of the above-mentioned genetically engineered bacteria. The gene encoding adenine deaminase on the genome of the host strain is knocked out to obtain a strain with high NAD+ yield. Or the expression cassettes of the gene encoding the enzyme in the NAD+ synthesis pathway are constructed separately, and then the enzyme encoding The gene expression cassette is integrated into the genome of the host strain whose gene encoding adenine deaminase is knocked out to construct a strain with high NAD+ production. The application of the above genetically engineered bacteria is disclosed. A method of producing NAD+ is disclosed.
Abstract: To provide a method for simply and precisely measuring cholesterol (LDL-C) in low-density lipoprotein in a sample without use of any surfactant having an alkylphenol structure, in terms of environmental friendliness. A method for measuring LDL-C in a sample, the method comprising: reacting the sample with (i) a combination of cholesterol ester hydrolase and cholesterol oxidase or (ii) a combination of cholesterol ester hydrolase, an oxidized coenzyme and cholesterol dehydrogenase, in an aqueous solvent which comprises: [a] one or more surfactants selected from the group consisting of a polyoxyethylene alkyl ether and a polyoxyethylene polyoxypropylene alkyl ether; and [b] a polyoxyethylene polyoxypropylene copolymer; and which does not comprise any surfactant having an alkylphenol structure; and measuring a substance formed or consumed in the reaction.
Type:
Grant
Filed:
August 30, 2018
Date of Patent:
December 17, 2024
Assignee:
HITACHI CHEMICAL DIAGNOSTICS SYSTEMS CO., LTD.
Abstract: Bone grafts and constructs including stem cells are provided. Example bone grafts include osteogenic stem cells seeded on a scaffold of osteoconductive cortico-cancellous chips and/or osteoinductive demineralized bone. Example constructs include extracellular matrix on a synthetic scaffold, in which the ECM is secreted from MSCs seeded onto the synthetic scaffold. Also provided are methods of making the present bone grafts and scaffolds. Further provided are methods of promoting bone healing and treating wound healing, by administering the present bone grafts and constructs to a mammal in need thereof. Also provided are kits that include the present bone grafts and/or constructs, or components thereof.
Type:
Grant
Filed:
August 18, 2023
Date of Patent:
December 10, 2024
Assignee:
Globus Medical, Inc.
Inventors:
Archana Bhat, Shairali Rao, Daniel Laskowitz
Abstract: A novel method of growing fungi is disclosed which uses an engineered artificial media and produces high density filamentous fungi biomats that can be harvested with a minimum of processing and from which fungal products such as antibiotics, proteins, and lipids can be isolated, the method resulting in lowered fungus cultivation costs for energy usage, oxygenation, water usage and waste stream production.
Type:
Grant
Filed:
August 11, 2020
Date of Patent:
December 3, 2024
Assignee:
THE FYNDER GROUP, INC.
Inventors:
Mark A. Kozubal, Richard E. Macur, Yuval C. Avniel
Abstract: The present invention is related to a combination useful in the prevention and/or treatment of red blood cell disorders, in particular, acute and chronic complications associated with red blood cell dysfunction, increased red blood cell cholesterol and decreased plasma levels of lipophilic antioxidant (sickle cell disease, thalassemia, diabetes). The invention in particular relates to pharmaceutical formulations, regimens, methods of treatment and uses thereof.
Type:
Grant
Filed:
July 26, 2017
Date of Patent:
November 26, 2024
Assignee:
HARTIS-PHARMA SA
Inventors:
Joseph Eric Niesor, Renee Benghozi, Francois Lamour
Abstract: A novel method for preparing an active protein peptide from connective tissue which includes steps of: connective tissue acquisition, segmenting, washing, pulverization, pH adjustment, enzymolysis, filtration, ultrafiltration, nanofiltration concentration, sterilization, freeze-drying, etc. The connective tissue protein peptide obtained by the method of the invention has features of high peptide content, high activity, etc., and the prepared active protein peptide of the connective tissue is easily absorbed by the human body, and has functions of preventing and/or alleviating and/or treating related diseases.
Abstract: Methods for obtaining a carboxylic acid product from a lactose-containing feedstock include contacting the lactose-containing feedstock and a first mixture of microorganisms in a first bioreactor under anaerobic conditions at a temperature of about 45° C. to about 55° C. and a pH of from about 4 to about 6 for a period of time such that lactic acid is formed; contacting the lactic acid with a second mixture of microorganisms in a second bioreactor under anaerobic conditions at a temperature of about 25° C. to about 35° C. and a pH of from about 4 to about 6 for a period of time such that the lactic acid is converted to one or more C3-C12 carboxylic acid products; and isolating the one or more C3-C12 carboxylic acid products. The lactose-containing feedstock has a pH greater than 4.5.